Literature DB >> 15505411

Ranking the role of RANK ligand in apoptosis.

A C Bharti1, B B Aggarwal.   

Abstract

Many members of tumor necrosis factor (TNF) superfamily are characterized by their ability to induce apoptosis once they bind in a homotrimeric manner to their cognate receptors. The receptor activator of nuclear factor-kappaB ligand (RANKL), a member of the TNF superfamily identified seven years ago, was originally described as a factor that induced osteoclastogenesis and dendritic cell survival. Recent observations indicate that a growth inhibitory and apoptosis-inducing activity is associated with RANKL, as is the case for other members of TNF superfamily. This review describes the possible mechanisms of induction of RANKL-induced growth inhibition/apoptosis and discusses the role of various components in RANKL-signaling in this phenomenon, including TNF receptor-associated factor (TRAF)-6, nuclear factor-kappaB (NF-kappaB), c-jun N-terminal kinase JNK), phosphatidylinositol-3 kinase (PI3K).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505411     DOI: 10.1023/B:APPT.0000045780.10463.c6

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  14 in total

1.  Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.

Authors:  Simone Reuter; Subash C Gupta; Kanokkarn Phromnoi; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.

Authors:  Lavinia Raimondi; Angela De Luca; Nicola Amodio; Mauro Manno; Samuele Raccosta; Simona Taverna; Daniele Bellavia; Flores Naselli; Simona Fontana; Odessa Schillaci; Roberto Giardino; Milena Fini; Pierfrancesco Tassone; Alessandra Santoro; Giacomo De Leo; Gianluca Giavaresi; Riccardo Alessandro
Journal:  Oncotarget       Date:  2015-05-30

3.  Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition.

Authors:  Bingshan Wu; Xueqin Yao; Xiaohu Nie; Ruxiang Xu
Journal:  DNA Cell Biol       Date:  2013-04-27       Impact factor: 3.311

4.  RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.

Authors:  Anna von dem Knesebeck; Jörg Felsberg; Anke Waha; Wolfgang Hartmann; Björn Scheffler; Martin Glas; Jennifer Hammes; Thomas Mikeska; Pearlly S Yan; Elmar Endl; Matthias Simon; Guido Reifenberger; Torsten Pietsch; Andreas Waha
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

5.  Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.

Authors:  Simone Reuter; Sahdeo Prasad; Kanokkarn Phromnoi; Ramaswamy Kannappan; Vivek R Yadav; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852

6.  Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development.

Authors:  Wei Li; Yiqin Xiong; Ching Shang; Karen Y Twu; Calvin T Hang; Jin Yang; Pei Han; Chieh-Yu Lin; Chien-Jung Lin; Feng-Chiao Tsai; Kryn Stankunas; Tobias Meyer; Daniel Bernstein; Minggui Pan; Ching-Pin Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

Review 7.  The role of CD40 and CD154/CD40L in dendritic cells.

Authors:  Daphne Y Ma; Edward A Clark
Journal:  Semin Immunol       Date:  2009-06-12       Impact factor: 11.130

8.  Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.

Authors:  Xiang Li; Yuxin Wang; Liangping Li; Shengji Zhou; Fengchao Zhao
Journal:  Cell Biol Toxicol       Date:  2021-01-09       Impact factor: 6.691

9.  Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.

Authors:  Shuangxin Liu; Wei Shi; Houqin Xiao; Xinling Liang; Chunyu Deng; Zhiming Ye; Ping Mei; Suxia Wang; Xiaoying Liu; Zhixin Shan; Yongzheng Liang; Bin Zhang; Wenjian Wang; Yanhui Liu; Lixia Xu; Yunfeng Xia; Jianchao Ma; Zhilian Li
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Integrin signaling in cancer cell survival and chemoresistance.

Authors:  Fawzi Aoudjit; Kristiina Vuori
Journal:  Chemother Res Pract       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.